Fondazione G.B.Bietti Per Lo Studio E La Ricerca In Oftalmologia — Clinical Trial Site

21 Registered trials

7 Currently recruiting

Organisation

Fondazione G.B.Bietti Per Lo Studio E La Ricerca In Oftalmologia

Location

Rome, Italy

Identifier

ORG-100046577

Address

Via Livenza 3, 00198, Italy

Departments

103; UOS Cornea, cristallino e oftalmoplastica
3507: U.O.S. Retina Medica
380004: UOS Retina Medica
Glaucoma
Glaucoma Unit
IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS
Medical Retina Unit
Oftalmologia
Ophthalmology
Presidio Ospedaliero Britannico
U.O.C Retina Medica
UOC di Oftalmologia
UOC Oculistica
UOC Oculistica Fondazione G.B.Bietti-IRCCS presso Ospedale Britannico
UR Glaucoma
UR Retina Medica

Clinical trials at this site (21)

Search interface

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy Pending

2023-505750-17-00 Neovascular age-related macular degeneration 4
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003) Recruiting

2025-524894-17-00 Neovascular age-related macular degeneration (NVAMD) 10 2026-06-22
An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED Recruiting

2025-523443-35-00 Persistent Corneal Epithelial Defect (PCED) 5 2026-06-11
A phase 2, double-masked, randomized, multicenter, parallel group, placebo-controlled study to investigate the efficacy and safety of GAL-10… Recruiting

2024-519128-26-00 Non-foveal geographic atrophy secondary to non-neovascu 4 2025-05-22
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneratio… Recruiting

2025-523704-77-00 Geographic atrophy secondary to age-related macular deg 4 2026-06-04
A phase IV, multicentre, open-label, single-arm study to investigate the efficacy, safety and durability of faricimab (RO6867461) in caucasi… Recruiting

2024-515640-22-00 polypoidal choroidal vasculopathy 6 2025-08-06
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2025-05-22
A study to assess efficacy of citicoline on visual field preservation in patients with glaucoma Recruiting

2022-502273-42-00 Glaucoma 5 2023-11-08
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended

2025-520809-12-00 Diabetic Macular Edema 10 2025-10-16
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Participants with Dry Age-Related Macular Degeneration… Ended

2024-515022-88-00 Dry Age-Related Macular Degeneration (AMD) with geograp 5 2025-03-03
A Phase 3 Study of Brepocitinib in Adults with Active, Non-Infectious, Non-Anterior Uveitis (CLARITY) Ended

2024-515089-15-00 active non-infectious uveitis (intermediate uveitis, po 5 2025-02-28
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema… Ended

2024-510944-30-00 Diabetic Macular Edema 10 2024-11-22
A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participan… Ended

2023-503666-23-00 Neovascular age-related macular degeneration 5 2024-06-07
A Study to Evaluate Long-Term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients with Neovascular Age-Related … Ended

2023-507131-38-00 Neovascular Age-Related Macular Degeneration (nAMD) 5 2022-05-16
A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System with Ranibizumab in Patients … Ended

2023-507130-24-00 Neovascular age-related macular degeneration (nAMD) 5 2021-10-22
A Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia Ended

2023-506707-25-00 Choroidal neovascularization secondary to pathologic my 5 2024-04-09
RANDOMIZED, OPEN LABEL, PARALLEL-GROUP, TWO-ARM, MULTICENTER STUDY WITH CLINICAL ENDPOINT COMPARING PRESERVATIVE FREE BIMATOPROST OPHTHALMIC… Ended

2023-504759-28-00 Ocular Hypertension 5 2024-04-05
A study to learn how well a higher amount of aflibercept given as an injection into the eye works and how safe it is in people with reduced … Ended

2022-502174-16-00 Macular edema secondary to retinal vein occlusion 5 2023-09-13
A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration Ended

2024-512880-30-00 Neovascular Age-related Macular Degeneration (wet AMD) 5 2021-08-27
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension Ended

2022-502380-37-00 Open-Angle Glaucoma 5 2019-08-02
A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edem… Ended

2023-507207-66-00 Diabetic Macular Edema (DME) 5